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Research continues to emerge indicating the potential destructive effects of 
non-nutritive sweeteners on the viability of gut microbe populations.  Recent 
trends demonstrate an increase in demand for natural and plant-based 
replacements for artificial sweeteners.  Yacon, lucuma, and monk fruit are novel 
ingredients that exhibit low calorie sweetening power in addition to 
multifunctional attributes that make them useful as alternatives to artificial 
sweetening substances.  Fermentable sugars contained within these sweeteners 
have the potential to display prebiotic impact for active growth of beneficial 
probiotic bacteria.  Lactic acid bacteria are a populous group of probiotic 
organisms with a long established history of consumption in fermented foods 
and an association with functional impacts on the structure of the gut 
microbiome.  There is little research pertaining to the influence of sucrose 
substitutes on the viability of probiotic bacteria, variable specificity of the 
different strains, and how compatibility with different sweeteners plays a major 
role in their survival.  In this study, we investigated the effect of novel 
sweeteners on the acidification of skimmed milk during fermentation with 
probiotic bacteria.  In culture medium, acidification kinetics were inhibited in 
the presence of the sweeteners, suggesting that the sugars and/or other 
compounds contained in the sweeteners displayed mechanisms of inhibition 
which possibly suppressed growth of the lactic acid bacteria.  However, there 
was no significant difference in viability (p > 0.05) between in treatments and 
control.  This study was limited and experiments were cut short by the sudden 
lockdown due to the Covid-19 pandemic.  It is suggested that future research 
employ chromatographic techniques to analyse the sugar composition of the 
sweeteners.  Viability analysis experiments which yielded inconclusive data 
should be repeated.  Additionally, variations in starter cultures may be explored 
for their specific enrichment of gut probiotic populations at the strain level.  A 
sensory component will help inform new product development.   
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1 Introduction  
With the steady rapid increase of easily accessible and available options for 
high-calorie, low-nutrition foods, the rates of obesity have continued to rise to 
epidemic proportions.  One way to reduce caloric intake is by reducing or eliminating 
the use of table sugar.  In search of the latest promise of taste satisfaction along with a 
reduction in calories, the market for new foods continues to grow, and manufacturers 
have responded to this need by producing and commercializing synthetic sweeteners.  
Despite government approval and assurance of safety, consumers remain sceptical of 
the sweeteners, and there are concerns about their long-term safety (Suez et al., 
2014).  
Research continues to emerge indicating that diet exerts a large effect on the 
gut microbiota (Donaldson et al., 2015), thereby suggesting that modulation of our 
diet may have a significant impact on our health (Wang, 2009).  The close relationship 
between diet, the gut microbiome, and health warrants further studies of more 
specifically what foods impact the microbiota.  Artificial sweeteners have been 
observed to alter gut microbiome composition (Wang et al., 2018).  For examples, 
aspartame, sucralose, saccharin, and stevia altered the gut microbiota, leading to 
dysbiosis and the development of glucose intolerance in mice (Suez et al., 2014).  
Some of the sweeteners have been shown to cause obesity and diabetes, an ironic 
result for something that is supposed to be a solution to these issues (Ruiz-Ojeda et al., 
2019). 
Recent trends demonstrate the turn away from industrialized, processed food, 
and an increase in demand for natural, plant-based products as acceptable substitutes 
for artificial sweeteners.  Functional foods (FF) are those that are considered to have 
an additional physiological benefit beyond basic nutritional requirements.  Yacon, 
lucuma, and monk fruit may be suitable replacements for artificial sweeteners that 
may compromise health.  These three natural sweeteners have certain associated 
health benefits and are gaining popularity with consumers in the U.S.  Additionally, 
these sweeteners do not create a strong residual flavour in food preparations such as 
NNS are known to.  The yacon tuber and the lucuma fruit have been used as traditional 
foods in South America for many years but the plants remain underutilized for their 
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potential as alternative sweetening ingredients in FF development.  The Asian fruit Luo 
han guo (“monk fruit“) has been traditionally used as a non-caloric sweetener (Zhang 
et al., 2011).  It is an accepted GRAS (Generally Recognized As Safe) ingredient that 
contains mogrosides, high intensity glycosides that are known to be 100-250 times 
sweeter than sucrose (USDA, 2017).   
A prebiotic is a non-digestible fibre that escapes digestion in the small intestine 
and is readily fermented in the colon, making them available to be metabolized by gut 
microbiota, thus conferring benefit(s) upon host health (Gibson et al., 2017).  Dietary 
intake of fibres and prebiotics exerts a positive impact on probiotic viability and 
enhances the intestinal microbiota.  Since prebiotics are naturally contained in fruits 
and vegetables, they offer a direct approach to manage the microflora through diet.  
Some sources of prebiotics also provide sweetening power and may be used as 
replacements for sugar or artificial sweeteners.  These plants remain underutilized for 
their potential as alternative sweetening ingredients in FF development.  A novel 
nutritional approach may be using these plant-based prebiotic ingredients to enhance 




The present work aims to understand the impact of lucuma, yacon, and monk 
fruit sweeteners on the growth of co-culture Lactobacillus delbrueckii subsp. bulgaricus 
and Streptococcus thermophilus used in the production of yoghurt.  Due to research 
indicating potential destructive effects of non-nutritive sweeteners (NNS) on the gut 
microbiome, we explored the viability of some relatively underutilized substitutes. It is 
hypothesised that since the sweeteners have prebiotic potential, it is postulated that 
they could enhance cell viability and growth when presented as a fermentation 
substrate for probiotic bacteria.  Through this potential, the sweeteners could be 
possible ingredients for applications in FF development.  
Another aim of this work was to conduct a narrative review analysing the 
findings of studies which examine the specific impact of NNS on the human gut 
microbiome and how this is associated with overall health or disease.  While the 
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literature on the natural sweetener alternatives is somewhat limited, a comprehensive 
review was conducted to explore the chemical characteristics of the sweeteners and 
make an informed conclusion as to their effect on the microbiome, and potential as 
replacement sweeteners in food development.  The chemical components of the 
sweeteners were investigated for their multifunctional characteristics, including 
medicinal properties, and as prebiotic agents with specific mechanisms that impact 
lactic acid bacteria and the gut microbiome as a whole. 
Due to the Covid-19 pandemic, this dissertation is a hybrid of literature review 
and laboratory experiments.  The objectives of this study are: 
1. To conduct a narrative literature review of artificial sweeteners, natural 
sweetener alternatives, bioactive components, prebiotic impact on 
probiotic bacteria, and the gut microbiome, in order to establish familiarity 
with and an understanding of research in these areas; 
2. To investigate the effect of lucuma, yacon and monk fruit sweeteners on 
the growth of yoghurt co-culture Lactobacillus delbrueckii subsp. bulgaricus 
and Streptococcus thermophilus in skimmed milk, by monitoring the change 
in acidification profile of the milk during fermentation and determining the 
cell viability in the end products; 










2 Literature Review 
2.1 Sugar, Artificial Sweeteners, and Health Concerns 
2.1.1 Sugar 
Despite early warnings of the impact of excessive sugar consumption on obesity 
and preventable health outcomes, global obesity rates have doubled over the last 20 
years.  Alongside the growing prevalence of obesity, the development of metabolic 
disorders such as type 2 diabetes (T2DM) is proportionally increasing.  At the start of 
this century, the number of people globally with T2DM was estimated to be 171 
million, and this number is expected to double by the year 2030 (Al-Goblan et al., 
2014).  Besides these alarming figures is the social and economic costs incurred, 
therefore the urgent need to control this epidemic cannot be understated.  The World 
Health Organization stresses that the limitation of nutritive sweeteners is an urgently 
necessary strategy to facilitate weight control and optimal nutrition (Gardner et al., 
2012).  While the exact causes of diabetes are still not fully understood, maintenance 
of a normal body weight (body mass index < 30) is central to prevention and treatment 
of T2DM.  Although all energy yielding food components have the potential to 
contribute to the positive energy balance that leads to weight gain, sugars are a huge 
source of hidden calories and provide no feeling of satiation, therefore a growing body 
of evidence indicates they are the major culprit in adverse health effects (Macgregor & 
Hashem, 2014).  The correlation between sugar and development of obesity and T2DM 
is well accepted, and the desire to limit sugar intake has been a major driver of the 
popularity of non-nutritive substitutes.  
2.1.2 Nonnutritive Sweeteners 
NNS are a chemically diverse group of synthetic compounds that contribute an 
intensely sweet taste and are used to replace white sugar while containing little or no 
calories.  They are categorised as high intensity sweeteners since they vary in power 
between several hundred and thousands times sweeter in reference to sucrose.  
Examples of NNS are aspartame, potassium acesulfame (ace-K), saccharin, and 
sucralose and they are commonly found in many beverages and convenience foods, 
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often without consumers realising their presence.  NNS are commonly used for 
diabetics and weight loss diets, however, consumption of NNS containing foods has 
increased among people of all ages, with 28% of the total U.S. population reporting 
intake (Shankar et al., 2013).   
NNS are regulated by the Food and Drug Administration (FDA), European Food 
Safety Authority, and the World Health Organization.  The FDA, which is a division of 
the U.S. Department of Agriculture (USDA) also publishes a Generally Recognized as 
Safe (GRAS) list of additives.  Hundreds of toxicological and clinical studies are 
reviewed to make determination of safety, however the Dietary Guidelines Advisory 
Committee, a group of experts that publishes a scientific report for the USDA and 
Health and Human Services, cautions that added sugars should be reduced and not 
replaced with NNS (Sylvetsky & Rother, 2018).  
The pathogenesis in the development of T2DM is based on the dysfunction of β-
cells of the pancreas which causes a lack of control of blood glucose accompanied by 
insulin resistance.  Diabetics are unable to control postprandial blood glucose without 
intervention.  Because of the significant role of sugar consumption in the development 
of obesity and T2DM, the medical community has supported the use of NNS for 
overweight/obese and diabetic patients as a way of reducing the glycaemic index (GI) 
of foods (Fitch & Keim, 2012).  The monitoring of carbohydrate intake and limitation of 
added sugars are the foundational strategies of the American Diabetes Association’s 
recommendations for achieving glycaemic control.  Evidence supports the notion that 
some carbohydrate sources are more favourable than others, depending on both their 
GI and fibre content, and there is a general consensus that diets low in GI are 
beneficial for the prevention and management of T2DM and other cardiometabolic 
diseases (Augustin et al., 2015).  The GI of a food represents the effect on postprandial 
blood glucose concentrations that the carbohydrate portion of a food has, compared 
with glucose or white bread.  Low-GI carbohydrates, such as fructose, lower peak 
postprandial blood glucose and have been shown to have a positive effect on glucose 
control (Sheard et al., 2004).  
Although NNS use is now widespread, the topic continues to be controversial 
due to insufficient data and conflicting evidence related to the effects on metabolic 
disease.  NNS are intended to prevent the morbidities that are known to be caused by 
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sugar, however some studies have demonstrated that their consumption is associated 
with adverse outcomes (Bright et al., 2017).  While some studies report an association 
between NSS use and reduced risk of obesity and T2DM (Wiebe et al., 2011); other 
studies suggest that NNS alter metabolic parameters and promote the weight gain and 
glucose intolerance that can lead to T2DM (Feijó et al., 2013).  An intervention study 
associated NNS consumption with a reduction in energy intake and a decrease in body 
mass index, compared to a sucrose consuming group (Wiebe et al., 2011).  Contrary to 
this, in another study weight gain was promoted by the use of NNS versus sucrose, 
independent of caloric intake (Feijó et al., 2013).  There are concerns that NNS could 
offset any weight loss benefits, having an impact on appetite regulation that causes an 
ironic compensation in overall caloric intake in addition to an altered glycaemic 
response (Bruyère et al., 2015).   
It is thought that NNS may cause a shift in microbiota populations by inhibiting 
the survival of certain bacteria, though the findings have been inconsistent.  Ace-K, or 
potassium salt of acesulfame, is about 200 times sweeter than sucrose and is 
metabolised in the body.  One study that looked at the effects of ace-K on microbiota 
showed no significant differences in Bacteroidetes to Firmicutes ratio, or overall 
bacterial abundance (Frankenfeld et al., 2015).  Conversely, another study 
demonstrated ace-K to augment microbiota composition and exert a strong 
bacteriostatic effect on E. coli (Bian et al., 2017a). 
Sucralose is 600 times sweeter than sucrose and is derived from sucrose by the 
selective replacement of three hydroxyl groups by chlorine atoms.  The sweetener is 
not digested, metabolised, or stored in the body (Magnuson et al., 2016).  Despite this 
finding, some research has shown sucralose to promote weight gain and metabolic 
disruption (Sylvetsky, 2018).  It is suggested that there is an interaction with sweet 
taste receptors in the intestine that increases the rate of glucose absorption and 
insulin secretion from β-cells.  The findings of one study revealed that the effects of 
sucralose on postprandial glucose metabolism can be differentiated between obese 
and normal weight participants, whereby higher plasma insulin concentrations were 
observed in the obese participants (Nichol et al., 2019).  Additionally evidenced in the 
literature is an altered gut microbiome whereby sucralose exerted a direct 
bacteriostatic effect on certain E. coli strains and promoted an increase in Firmicutes.  
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The mechanisms vary between species but are thought to either inhibit metabolic 
enzymes or alter nutrient transportation (Wang et al., 2018). 
Unlike most other NNS, aspartame is metabolised in the human body, breaking 
down into its components (phenylalanine, aspartic acid, and methanol) via enzymes in 
the digestive tract (Kroger et al., 2006).  Since the end products are absorbed without 
passing through the colon, it is thought they do not come into direct contact with the 
microbiota and are therefore metabolically inert (Magnuson et al., 2016).  
Nevertheless, aspartame has been shown to cause dysbiosis of gut bacteria in mice, 
and a shift in microbial composition with an increase in Clostridium leptum and 
Enterobacteriaceae populations (Palmnäs et al., 2014).  Like sucralose, it is unclear 
what the mechanics are behind this effect and more research has been necessitated.  
Effects of NNS on the gut microbiome will be further explored in section 2.6. 
Saccharin is the oldest NNS approved for food and beverage use in the United 
States (Fitch & Keim, 2012).  Studies have related an increase in weight gain of mice 
consuming saccharin when compared to groups fed with sucrose, despite similar 
caloric intake (Feijó et al., 2013).  Consistent with this, another study showed that 
consumption of saccharin can promote excessive intake relative to glucose by reducing 
caloric compensation (Suez et al., 2014).  A plausible explanation for this is that the 
short-term caloric deficit leads to a lowered resting metabolic rate, which leads to an 
increase in long-term weight gain.  Although using NNS may support the displacement 
of sugar in the diet, they may fail to compensate for satiety, possibly causing a higher 
overall caloric intake.   
Research has demonstrated paradoxical associations with the consumption of 
NNS, demonstrating that they can help reduce added sugar intake in the diet and may 
support weight loss and diabetes management.  Still, although the underlying 
mechanisms are compound specific, studies have made associations between artificial 
sweetener consumption and weight gain, impaired insulin sensitivity, metabolic 
syndrome, and a statistically significant increase in risk of T2DM (Anton et al., 2010; 
Gardner et al., 2012).  These results raise the question of whether NNS are fuelling the 
epidemic they are intended to prevent (Fowler et al., 2008).  Consumers remain 
sceptical of NNS, and the scarcity of data regarding the safeness of these substances, 
leads to a great need for natural sweetener alternatives.  
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2.2 Natural Sweetener Alternatives 
Along with the interest in sugar reduction, consumer preference for ingredients 
of natural origin has driven continued industrial focus on “clean” label formulations.  
Recent trends demonstrate the turn away from industrialised, processed food, and an 
increase in demand for natural, plant-based products as superior replacements for 
artificial sweeteners (van Gunst & Roodenburg, 2019).  Due to the perceived risk of 
synthetic additives, consumers are willing to pay a premium for foods that are absent 
of these substances (Migliore et al., 2018).    
Among natural alternatives to sucrose and artificial sweeteners, and favoured 
due to their low glycaemic index are lucuma and yacon (Mérillon & Ramawat, 2018).  
Native populations of the Andean region have long cultivated these two crops, using 
both for diet and for traditional medicine (Fuentealba et al., 2016).  According to 
European Novel Food Regulation (258/97), safety approval is required for foods 
without a significant history of consumption within the European Union before 15 May 
1997.  Lucuma and yacon are foodstuff with sweetening properties and not food 
additives with an E-number classification, and not subject to the Novel Food 
Regulation (Hermann, 2009).  The whole plants are typically dehydrated and milled 
into a flour and do not undergo any refining process, therefore may provide a high 
content of beneficial nutrients and bioactives (Belščak-Cvitanović et al., 2015).  A third 
sweetener which will be explored is monk fruit, which is in the category of high 
intensity non caloric sweeteners extracted from plants.  In the United States, monk 
fruit extract was accepted as a generally recognized as safe (GRAS) ingredient in 2010, 
approved for its non-nutritive sweetening and flavour enhancing purpose (USDA, 
2017).  It is also approved for use in New Zealand, Australia, and Japan, though it has 





Figure 1  
Lucuma Fruit and Powder 
 
Lucuma (Pouteria obovata) is from a subtropical fruit tree belonging to the 
Sapotaceae family. The lucuma fruit is native to the temperate highlands of the 
Peruvian Andes and its use dates back to the Inca civilization (Duarte & Paull, 2015).  
Although Peru is the main producer, cultivars are also grown in highlands of Ecuador, 
Chile, California (United States), Mexico, Bolivia and Costa Rica.  The fruits are divided 
into two varieties based on the consistency of their pulp: lucuma-seda with a softer 
flesh that is more appropriate to be eaten fresh, and lucuma-palo with a dense flesh 
that is consumed as a dried form (Gómez-Maqueo et al., 2020).  Lucuma fruit is round 
or ovaloid, green with a deep yellow-orange coloured flesh that is indicative of its high 
carotenoid content (Figure 1).  Ripe fruits are dehydrated and milled into a mealy flour 
to extend storage, and the highly pigmented and somewhat dry pulp has a texture 
similar to pumpkin (National Research Council, 2000).  Flour is prepared by selecting, 
disinfecting, peeling and seeding the fruit then drying at 60°C in hot air tunnels (Yahia, 
2011).  With a distinctive flavour that has a sweet taste that resembling caramel, 
butterscotch, or maple, the fruit could be used to flavour beverages, preserves, 
pudding, yogurt, ice cream, cake and cookie fillings, and other desserts (Ma et al., 
2004).   
Fruits of the Sapotaceae family have been established as a rich source of novel 
anti-inflammatory polyphenols and antioxidant compounds (Brizzolari et al., 2019).  
One study determined lucuma to have the highest concentration of phenolic 
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compounds among other Peruvian fruits (Silva et al., 2009).  Lucuma fruits are a good 
source of calcium, iron, niacin, and vitamin C, and the flour is very high in total dietary 
fibre (which is mainly in the insoluble form).  The cultivar most commonly used for 
commercial production of flour is the Palo variety, which was shown to contain 31.7% 
insoluble fibre, and this is noted to be much higher than in other fruits such as 
pineapple, mango, or papaya.  For a fruit, lucuma are significantly high in protein, with 
1.5g - 2.4g per 100g of fresh pulp and up to 4g in the flour.  They are low in acidity and 
high in reducing sugars (Glorio et al.,, 2008).  Sugar content varies greatly in both 
biotype and maturity of the fruit, with unripe fruit containing primarily sucrose and 
sugar conversion leads to increased amounts of glucose and fructose throughout 
ripening stage.  The sugars present in ripe lucuma fruit in order of highest to lowest 
abundance are glucose, fructose, sucrose and inositol (Yahia, 2011).  In three different 
biotypes analysed for sugar content at commercial ripeness, fructose ranged between 
18.8 ± 4.2 and 127.1 ± 34.9 mg/g DW (dry weight), glucose between 24.8 ± 7.0 and 
173.3 ± 65.9 mg/g DW, and sucrose between 41.2 ± 13.8 and 77.5 ± 22.5 mg/g DW 
(Fuentealba et al., 2016). 
To control diabetes, it is important to regulate insulin sensitivity and 
postprandial blood glucose level.  α-glucosidase is a digestive enzyme that participates 
in glucose digestion, and inhibition of this enzyme delays the degradation of starches 
to glucose.  Agents with intestinal α-glucosidase inhibitory activity have been useful as 
oral α-glucosidase inhibitors (AGI), which play a major role in glycaemic regulation.  A 
recent study found aqueous extracts of lucuma to behave as an AGI, producing a 
hypoglycaemic effect and attenuating blood glucose level, suggesting that lucuma may 
be a food-based treatment to complement diabetes management (Silva et al., 2009).  
Because of the fruit’s rich bioactive compound content and antihyperglycaemic effect, 
lucuma could be an underutilised ingredient with great potential for innovation and 




adjacent fructose units.  Yacon is noted to contain the highest concentration of 
fructans with a low molecular weight and low DP (Choque Delgado et al., 2013).  
Chemical composition in yacon tubers may vary considerably depending on factors 
including genotype variation, planting location, growing season, harvest time, and 
post-harvest temperature.  FOS have been cited to make up the bulk of total 
carbohydrates in yacon, varying between 40% and 70% of dry weight.  Carbohydrate 
content is especially affected by post-harvest storage time and a traditional process of 
sunlight exposure that dehydrates the roots and accelerates the depolymerisation of 
FOS into sucrose and reducing sugars (glucose and fructose) (Graefe et al., 2004).   
FOS have about half the calories per gram than sucrose or glucose, with a 
sweetness of 0.3–0.6 relative to sucrose (Mérillon & Ramawat, 2018).  The glucosidic 
bonds of FOS cannot be hydrolysed thus are not metabolised in the human digestive 
tract and several studies have shown that their consumption does not augment blood 
glucose levels.  More human clinical trials are needed however several studies have 
associated health benefits with FOS consumption, including weight management and 
obesity prevention in overweight adults (Yan et al., 2019).  A 12 week trial looked at 
the effects of FOS supplementation on body weight in healthy adult subjects with a 
body mass index (BMI) >25.  The study obtained results of a reduction in body weight 
of 1.03 ±  0.43 kg in healthy adults compared to a non-FOS consuming control group 
which gained 0.45 ±  0.31 kg (Slavin, 2013).  Yacon is already acknowledged as a 
medicinal plant in its native regions, and commonly used as a remedy for diabetes 
management.  Yacon roots are a good source phenolic and antioxidant compounds 
(Campos et al., 2012).  The bioactivity of yacon is further discussed later in this 
document.  Yacon perhaps remains underutilised and could be well positioned as an 





Figure 3  




2.2.3 Monk Fruit 
 
Figure 4  
Monk fruit and powder 
 
Monk fruit (Siraitia grosvenorii), also known as luo han guo (Figure 4), is grown 
on a perennial vine indigenous to Asia, where it has been utilised for over 200 years 
(Zhang et al., 2011).  The main component is mogroside, which are cucurbitane-type 
triterpene glycosides reported to be 100-250 times sweeter than sucrose (Itkin et al., 
2016).  Whole monk fruit contains sugars including fructose and glucose, but monk 
fruit extract are isolated mogrosides obtained by a process of water extraction, 
filtration, and selective concentration of the sweet glycosides.  Depending on the 
manufacturing process, commercially available monk fruit products have varying 
concentrations of mogroside V, which is the main mogroside (Figure 5).  The remainder 
of the product may be comprised of any combination of other terpene mogrosides, 
protein fragments, melanoidins, or flavonoids (Quinlan & Zhou, 2017).  
In addition to its use as a natural sweetener, monk fruit is highly valued in 
traditional Chinese Medicine as a useful remedy for ailments which require cooling 
properties, such as sore throats, coughs (Li et al., 2014).  More recently, it has been 
researched for the pharmacological potential of mogrosides to serve as an agent with 
antidiabetic, anticarcinogenic, antibacterial and antioxidant properties (Suzuki et al., 
2007).  Mogroside V may also be valuable as a chemopreventive agent, due to its 




Mogrosides confer the sweet taste without increasing blood glucose (Pandey & 
Chauhan, 2019).  In vitro evaluation of antioxidant capacity in mogroside V revealed 
strong oxygen free-radical scavenging activity, indicating an ability to counteract the 
oxidative stress induced by diabetes (Suzuki et al., 2007).  In addition, studies have 
indicated that the administration of the extract may contribute to the prevention of 
diabetic complications associated with oxidative stress and hyperlipidaemia (Qi et al., 
2008).  In studies of diabetic rats that ingested maltose, mogrosides were shown to 
strongly supress rising postprandial blood glucose levels, exhibiting the potential to 
attenuate early clinical symptoms of T2DM (Jin & Lee, 2012).  Mogrosides are a 
botanically derived AGI, inhibiting postprandial glucose peaks, thereby decreasing 
post-load insulin levels (Ghosh & Collier, 2012).  Monk fruit’s suitability as a plant 
derived sweetener, in addition to its role in disease prevention, indicates that it may 










     
 Figure 5 
 Chemical Structure of Mogroside V  (Zhang et al., 2011). 
 
2.3 Bioactive Components 
Many plants have been historically considered to be medicinal substances and 
can be utilised as nutraceuticals in the modern age.  Fruits and vegetables contribute 
the protective health promoting factors and biologically active (bioactive) compounds 
which act in reducing the oxidative stress that leads to cellular damage.  Plants contain 
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a heterogeneous collection of bioactive compounds which includes fermentable fibres, 
in addition to many antioxidant compounds including phenolic compounds, 
carotenoids, anthocyanins, coumarins, tannins, and tocopherols.  Plant phenolic 
compounds (phenolics) are a diversified group of phytochemicals which includes a 
large subsection of chemicals called polyphenols, which can be further classified into 
lignans, phenolic acids, stilbenes, and flavonoids (Figure 6).  The most widely 
distributed group, flavonoids are a family of phenolic compounds based upon the 
characteristic phenol structure of a benzene ring with at least one hydroxyl group 
bound to one or more aromatic rings.  The various classes are defined by differing 
position and placement of functional groups on the carbon backbone (Baião et al., 
2017).  They occur as glycosides (glucosides, galactosides, arabinosides, xylosides, and 
rhamnosides) which are stored bound to sugar moieties within the plant, requiring the 
sugar group (glycone) to be split from the polyphenol (aglycone) to render them more 
bioavailable.  The absorption of dietary flavonoids liberated from food by chewing 
depends on their physicochemical properties such as molecular size and structure, 
configuration, and solubility.  The majority of flavonoid glycosides do not meet the 
substrate specificity of digestive enzymes in the upper intestine and continue their 
journey to the colon, where they are hydrolysed and converted into their aglycan form 
by bacteria (Kumar & Pandey, 2013).  Flavonoids possess strong antioxidant activity 
that is known to prevent the cell membrane oxidation which has been linked to the 
onset of numerous chronic diseases including cardiovascular (atherosclerosis, coronary 
heart disease, and heart attacks), neurodegenerative (Parkinson’s and Alzheimer’s), 
diabetes mellitus, cancer and inflammation (Ribas-Agustí et al., 2018).  As dietary 
components in humans, flavonoids are protective due to their high antioxidant 




          
 Figure 6   
Chemical Classification of Polyphenols (Piccolella & Pacifico, 2015). 
 
    
In food, phenolics may contribute to the bitterness, astringency, flavour, odour, 
colour, and oxidative stability.  Food matrix composition has a great influence when 
evaluating bioaccessibility and bioavailability of phenolic compounds.  In order to be 
bioavailable and render preventative health benefits, dietary phenolic compounds 
must be either released from the food matrices during small intestinal digestion 
(bioaccessible) or as a result of the transformative metabolism of dietary fibres in the 
colon, in which microbiota play a crucial role (Bohn, 2014).  In a western diet, it is 
estimated that about 50% of phenolic compound intake is associated with dietary 
fibre.  Diets that are abundant in plant foods have demonstrated the promotion of a 
stable GM profile, which may be due – at least partially – to the presence of fibre and 
polyphenols.  Indeed, dietary fibre and polyphenol intake is consistently associated 
with increases in the growth of beneficial bacteria Bifidobacterium and Lactobacillus 
and other lactic acid bacteria which yield metabolites that provide antioxidant and 
anti-inflammatory effects (Singh et al., 2017).   
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2.3.1 Phenolic Compounds in Natural Sweetener Alternatives 
The sweeteners that are the focus of this work were found to contain various 
phenolic compounds, which elevates their dietary value and possible applications in 
nutraceuticals (Table 1).  Yacon tubers are multifunctional foods that not only contain 
an abundance of health promoting FOS but also are rich in bioactive compounds such 
as phenolics up to 3.8% on a dry weight basis, although can significantly vary according 
to cultivar, environmental conditions during cultivation, post-harvest, and processing 
conditions (Campos et al., 2012).  Recent research has identified 25 bioactive 
compounds in yacon, such as tryptophan and caffeic acid.  Tryptophan, an essential 
amino acid important to intestinal microbiota and brain function, exerts a positive 
effect on carbohydrate metabolism in hepatocytes due to increased activity of key 
enzymes (glycokinase, hexokinase, and glucose-6-phosphate dehydrogenase).  
Chlorogenic acid is the most abundant hydroxycinnamic acid in yacon and was shown 
to modulate plasma insulin concentration and inhibit of hepatic gluconeogenesis 
(Gomes Da Silva et al., 2017).  The antidiabetic effects of yacon root hydroalcoholic 
extract in streptozotocin-induced diabetic rats have been attributed to its antioxidant 
activity and hypoglycaemic effect of important phenolic compounds, mainly 
chlorogenic acid (Choque Delgado et al., 2013).  Besides the flesh processed into 
sweetener, some of the bioactives are found in other portions of the plant such as the 
leaves, stems, and flowers, either in higher amounts or exclusively.  While the peel 
portion of yacon frequently contains a higher bioactive content, it also has a higher 
concentration of oxidation catalysts, and must therefore be completely removed in 
commercial processing (Manrique et al., 2005).  Yacon flesh rapidly turns brown once 
the root is peeled, therefore agents such as ascorbic acid, and cysteine are used to 
control the main oxidising enzyme, polyphenol oxidase.  The distribution of sugars in 
the yacon root is such that the concentration of sugars increases from the centre to 
surface, and for this reason care must be taken in peeling since the highest FOS 
content is located right beneath the skin (Manrique et al., 2005).   
Other fruits of the Sapotaceae family have been the focus of most research and 
studies that characterise and quantify the bioactive metabolites in lucuma have been 
limited until very recently (Fuentealba et al., 2016).  Lucuma powder was reported to 
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contain a higher amount of phenolics (51.1 mg GAE/1000 g) than dehydrated fruits 
usually used in snacks, such as apples (14.30 mg/1000 g), blueberries (14.30 mg/1000 
g), peaches (9.69 mg/1000 g), and strawberries (34.71 mg/1000 g) (Dini, 2011).  Total 
Phenolic content (TPC) was shown to decrease as lucuma ripens, and the ripeness 
stage was shown to greatly impact levels of primary and secondary metabolites such 
as sugars, organic acids, and carotenoids.  Total carotenoid content in lucuma was 
reported to be between 9-20mg / 100gFW, a high value considering carrots have 
carotenoid value between 10-40mg / 100gFW.  There are many carotenoids besides β-
carotene in lucuma which still require identification and quantification (Fuentealba et 
al., 2016).  A recent study noted that anti-hyperglycaemic effect in lucuma is related to 
the high concentration of triterpenoid α-amyrin, which supports glycaemic control due 
to α-glucosidase inhibitory activity (García-Ríos et al., 2020). 
Several important bioactive components that possess broad pharmacological 
properties have been isolated from monk fruit such as triterpenoids, flavonoids, and 
amino acids.  Mogrosides are the main bioactive components in monk fruit, and 
currently over 60 types of mogrosides have been identified (Wang et al., 2019b).  The 
major flavonoid component of monk fruit is grosvenorine, which is metabolised by gut 
microbes producing metabolites with potent antibacterial action.  In the early stage of 
immature fruit, Mogroside II is predominant; while in the later stages of maturity, 
more glycosylated sweet mogrosides (V) develop and accumulate (Wang et al., 2019b).  
In extracts, the amount of mogroside is highly variable depending on the extraction, 
purification and concentration process, with concentrations of mogroside V varying 
from 25 to 55% of the crude extract (Younes et al., 2019).  There are a few significant 
biological aspects of mogrosides that evidence monk fruit’s value as a medicinal food.  
Mogroside extract inhibited histamine release from mast cells in mice demonstrating 
its antihistamine properties, antioxidant activity was indicated through the effective 
elimination of free radicals, and inhibition of cancer cell promotion and progression 
suggests the capacity to act as a chemopreventative agent (Gong et al., 2019; Takasaki 








nutrient absorption, and maintaining gut immune homeostasis.  Microbiota metabolise 
flavonoids and create phenolic intermediates.  Some polyphenols are catabolised to 
unique products such as flavan-3-ols and ellagitannins, which have beneficial functions 
in the gut such as the modulation of gene expression in colon cancer cells (Pei et al., 
2020).   
 
2.4 Probiotic Bacteria 
Probiotics are defined as living microorganisms that confer a health benefit on 
the host when administered in adequate amounts (Hill et al., 2014).  The International 
Scientific Association of Probiotics and Prebiotics (ISAPP) established this evolving 
concept regarding the strain specificity of probiotic effects:  different strains express 
different mechanisms, although at times common mechanisms may be shared 
amongst strains of a larger taxo (Sanders et al., 2018).  Probiotic bacteria can be 
delivered through food sources or dietary supplements, including fermented dairy 
such as yoghurt or kefir (Kumar et al., 2015).   
2.4.1 Lactic Acid Bacteria 
One of the most significant groups of probiotic organisms is Lactic acid bacteria 
(LAB).  They are a diverse group of Gram-positive, non-spore forming, acid tolerant 
bacteria which are all dependent on the presence of fermentable sugars for active 
growth.  A total of 16 genera make up the LAB group, with Lactobacillus as the largest 
genus, and 12 genera are used in food.  Lactic acid is the major end product of sugar 
fermentation, and LAB may be either homofermentative, producing more than 85% 
lactic acid, or heterofermentative, producing lactic acid in addition to CO2, ethanol 
(and/or acetic acid) in equimo(Holzapfel, 1995)(Holzapfel, 1995).  Through their 
fermentation of carbohydrates, LAB provide for a great enhancement of flavour and 
texture in food products, in this way contributing to a pleasant sensory profile of the 
end product (Narvhus & Axelsson, 2003).  Specific strains create inhibitory effects on 
certain pathogenic microorganisms, but LAB can also limit the invasion of pathogenic 
bacteria by multifactorial means, which involve the production of different inhibitory 
compounds and competitive exclusion for binding sites on the gut epithelium and for 
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nutrients.  The exclusion may be attributed to the formation of biofilms which render 
pathogens unable to adhere to the intestinal epithelial mucosa, thereby reducing 
colonisation and preventing infection (Wedajo, 2015).  LAB also produce bacteriocins, 
antimicrobials and organic acids such as lactic acid, acetic acid, and formic acid, which 
can be applied to prevent spoilage and to inhibit foodborne pathogens such as 
Clostridium botulinum, Staphylococcus aureus, and Listeria mo(Leroy & De Vuyst, 
2004)(Leroy & De Vuyst, 2004).  The fortification of intestinal flora components to 
increase gut resistance to pathogenic invasion may be a rational way to support 
prevention or treatment of gut related conditions such as peptic ulcers, ulcerative 
colitis, and Candida overgrowth, in addition to chronic gut disorders such as irritable 
bowel syndrome (IBS), inflammatory bowel disease (IBD), and colon cancer (Manning 
& Gibson, 2004).  
2.4.1.1 Probiotic Effect of Lactic Acid Bacteria 
Beneficial association of lactic acid producing microorganisms with the human 
host and dates back to studies of gut ecology at the turn of the twentieth century.  Elie 
Metchnikoff, regarded as the father of modern probiotics, is credited with introducing 
lactobacilli as probiotics to promote health, however Lactobacillus bulgaricum was 
named after the physician, Stamen Grigorov, who first identified the LAB in Bulgarian 
yoghurt (Walter, 2008).  To this day the health improving mechanisms are still not fully 
understood but are suggested to relate to pathogen interference, exclusion or 
antagonism, modulation of the immune system, anticarcinogenic activity, amelioration 
of lactose intolerance, lesser diarrheal incidence and duration, and prevention of 
urinary and vaginal infections (Wedajo, 2015).  LAB transiently colonise the human 
gastrointestinal tract (GIT) but some LAB strains can survive and colonise the gut 
longer term, having the capacity to alter the composition of the gut microbiota 
through their production of beneficial fermentation-derived metabolites (Wang et al., 
2017).  Bifidobacterium and Lactobacillus produce organic acids known as short chain 
fatty acids (SCFA) in the colon via the fermentative pathway.  Carbohydrates are 
metabolised into SCFA such as lactate and acetate, providing a range of potential 
benefits to the intestinal tract and beyond.  LAB also play an important role of 
interaction with cells on the gut wall, inhibiting undesirable microbes and cross-
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feeding other beneficial gut microbes, resulting in production of the SCFA butyrate, 
which fuels intestinal epithelial cells in the large intestine.  SCFA may also be absorbed 
and transported to the peripheral circulation via the portal vein to act as signalling 
molecules on the liver and peripheral tissues, regulating hormonal and nervous system 
processes in the host.  Thus, SCFA produced commonly by many different probiotic 
strains and species are an essential contribution to the proliferation of the GIT  
(Topping & Clifton, 2001).  Lactobacillus is among the genera capable of converting 
tryptophan to indolealdehyde, an indole metabolite that has positive impact on 
neuroendocrine function and immune response.  These microorganisms may not 
necessarily be constant inhabitants of the GIT but colonisation isn’t necessary for 
probiotics to have a functional impact on the structure of the GM beyond their 
temporary effects (Hungin et al., 2018). 
2.4.1.2 Lactic Acid Bacteria Fermentation 
The group of LAB has a long and safe history of application and consumption in 
the production of fermented foods and beverages, thus are very important to the food 
industry (Holzapfel, 1995).  Fermentation is an ancient technology that began as a 
spontaneous process which occurred due to wild microflora that are naturally present 
in the environment.  The utilisation of LAB by humans has a very long history and the 
earliest record of human use of LAB can be dated back more than 10,000 years ago as 
supported by archaeological evidence (Bintsis, 2018).  Though likely a spontaneous 
rather than intentional event, the first fermentation dairying occurred more than 8000 
years ago when North African residents consumed natural acidified milk products.  
Small amounts of previously generated fermentations could be used to inoculate new 
batches repeatedly and infinitely, as in the production of sourdough bread.  Production 
of fermented foods is a cost effective and reliable preservation method, and 
additionally is appreciated for unique gastronomic virtues (Leroy & De Vuyst, 2004).   
A starter culture can be defined as a microbial preparation of a large number of 
cells of at least one microorganism to be added to a raw material to produce a 
fermented food by accelerating and steering its acidification process.  The production 
of lactic acid via thermophilic fermentation of lactose by the starter culture is the 
foundation of cultured milk products such as yoghurt.  LAB are commonly employed in 
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the food industry, with their main application as starter cultures for fermented dairy 
products.  Starter cultures are added directly to raw materials to initiate the 
acidification process and achieve a controlled fermentation.  The resultant acidifying 
compounds contribute to sensory attributes such as aroma, flavour, and texture with a 
characteristic tang.  When homofermentative LAB convert sugar (lactose in the case of 
dairy products) into lactic acid via pyruvate, other metabolites may be produced, 
lending to the typical flavour of certain fermented foods, such as ethanol (kefir) and 
acetaldehyde (yoghurt) (Bintsis, 2018).  Lactobacillus delbrueckii subsp. bulgaricus and 
Streptococcus thermophilus are two species with a symbiotic interaction for growth 
and acidification, making this co-culture ideal for yoghurt manufacturing.  The synergy 
between these two homofermentative species is the basis for successful milk 
fermentation and gelation.  Early in fermentation, S. thermophilus leads the acid 
production and reduces pH to an optimal level for L. bulgaricus to grow and start also 
metabolising lactose into lactic acid.  Lacking essential proteolytic activity, L. bulgaricus 
grow slowly in milk and are associated with high acidity and bitterness, thus they are 
usually combined with non-proteolytic S. thermophilus for a more effective 
fermentation, more rapid acid production, and creation of flavour compounds 
(Sieuwerts, 2016).  
Acid gelation is a fermentation process that requires the associative action of 
two or more species.  At the initial stages, Streptococcus species convert lactose to 
lactic acid, and as the concentration of lactic acid increases to 1% Lactobacilli start 
acting at around pH 5.  Caseins are coagulating proteins in milk that assemble into  
micellar structures by the joining of phosphoserine molecules to each other through 
molecules of amorphous calcium phosphate.  The casein micelles are suspended in 
milk through steric stabilisation forces and they have a negative charge at pH 6.7.  As 
the pH of milk drops from 6.7 to 4.6, calcium phosphate gets solubilised causing the 
caseins to fall apart from the micelles.  Protonation of the caseins takes place as 
acidification progresses.  The isoelectric point is reached at pH 4.6, when the caseins 
are not charged and fall out of solution.  This is the point of acid gelation and it is 
believed that the casein chains entrap water and form loose networks with each other.  
The gel formed in this way is called yoghurt (Huppertz et al., 2018). 
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In the production of yoghurt, specific procedures and growth conditions must 
be met.  First the milk is standardised, or adjusted for the desired content of solids, 
casein, and fat.  Next the milk is homogenised to increase the number of fat particles 
that contribute to an increased viscosity and in addition reduces whey separation.  
Some fermented dairy products such as sour cream undergo a second homogenisation 
which encourages clustering of fat globules that further increases the viscosity of the 
product.  Pasteurisation prevents the growth of any competing microbes and spores 
and reduces the microbial load of other non-pathogenic bacteria.  Also, oxygen level is 
reduced, creating an improved environment for starter bacteria to grow.  Heat 
processing at or above 90°C denatures whey.  The milk is cooled to an optimal 
temperature for the relevant bacteria culture before the starter is added and the 
mixture is incubated, usually between 40-45°C for L. bulgaricus.  Temperature is a 
critical variable that influences kinetic progress (and therefore acidification and rate of 
gel formation) during fermentation.  Acidification by LAB impacts the gelation of casein 
and at around pH 5, caseins begin to denature and reassemble in a network of 
molecules.  These casein micelles are the building blocks of casein-based gels that 
provide the distinctive coagulated texture of yoghurt.  This growth phase and acid 
production continues until a final pH of 4.2-4.5 is achieved and the gel is formed, at 
which point the cultures start to become inhibited by the low pH and excess of acid 
and hydrogen peroxide.  Too short or long of a fermentation time also results in 
impairment of consistency and flavour, therefore the yoghurt is usually blast chilled 
then stored at 5°C to slow down degradation.  Gel viscosity and firmness increases in 
the cooled product due to an increase in the size of casein particles (Lucey, 2004).   
2.4.2 Effects of Sweeteners on Starter Cultures 
The introduction of sweeteners into a food product can result in significant 
sensory alterations, particularly in appearance, texture, and flavour; yet there is little 
known about the influence of sucrose substitutes on the viability of probiotic bacteria.  
Retention of viability of probiotic cultures during processing is a major challenge in the 
development of functional foods (Farnworth, 2003).  The inclusion of live active 
cultures into a food matrix has been recognised to impart several technological 
challenges which may detrimentally affect their growth, viability, and functionality 
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during production and storage (Lee & Salminen, 2009).  Stress factors the bacteria may 
encounter include temperature, pH and titratable acidity, and exposure to osmotic and 
oxidative stress in product matrices  (Mohammadi & Mortazavian, 2011).  Additional 
key factors are the presence of antimicrobial agents such as hydrogen peroxide, 
bacteriocins, SCFA, some flavouring agents, salt, sugar, sweeteners, artificial 
flavouring, colouring agents, and other additives.  In order to deliver their health 
benefits, probiotics must adapt and survice in variable environments (Terpou et al., 
2019).  
Conjugated linolenic acids (CLA) are a diverse group of positional and geometric 
isomers of linolenic acid with conjugated double bonds.  CLA have received a 
nutraceutical food status, and they are predominantly found in milk and meat 
products.  LAB produce CLA from linolenic acid, and CLA conversion by LAB can be 
influenced by bacterial strain, incubation time and cell age.  Lipolytic activity of starter 
cultures has been shown to be influenced by the addition or modification in 
ingredients in yoghurt and can result in modified fatty acid profiles.  In the presence of 
sucrose, the inhibition of fatty acid production in starter culture was observed.  In a 
study which looked at the effects of the addition of sucrose, lactose, and fructose on 
CLA level in skim milk medium after incubation varied with lactic cultures, all three 
sugars strongly inhibited the level of CLA produced by L. delbrueckii subsp. bulgaricus 
and L. acidophilus.  Sucrose and fructose showed an inhibition on CLA produced by L. 
delbrueckii subsp. lactis and S. thermophilus, yet conversely, fructose promoted an 
increase in CLA level of 22% with Lactococcus lactis subsp. cremoris.  This 
demonstrates the variable specificity of probiotic strains and how compatibility with 
different food ingredients plays a major role in their survival (Lin, 2000).  
NNS were evaluated for their effect on the viability of probiotic cultures in 
yoghurts.  The sweetener ace-K and aspartame were observed to not be inhibitory 
towards lactic acid starter at the concentration normally used in dairy drinks, however 
at a higher concentration, aspartame was inhibitory towards S. thermophilus and two 
strains of L. lactis (Vinderola et al., 2002).  A different study which determined 
probiotic survival in yoghurts showed that NNS in place of sucrose showed no negative 
impact on probiotic viability (Esmerino et al., 2013).  Research has indicated that some 
fruits have the potential to perform as substrates to improve probiotic viability, while 
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other fruits have demonstrated inhibitory effects (Vinderola et al., 2002).  Yoghurts 
with stir-in fruits have shown improved survival of L. acidophilus, possibly due to a 
reduction in L. bulgaricus.  However, some fruit juices or pulps may adversely affect 
probiotic survival, depending on bacteria strain, due to higher acidity or antimicrobial 
components in the fruits (Shori, 2016).  In a study that added monk fruit extract to 
yoghurt, there was a significant enhancement of L. casei viability, along with 
antibacterial activity against E.coli, Salmonella typhimurium, and Listeria 
monocytogenes, compared to a control yoghurt with no sweetener added.  It is 
believed that this antimicrobial action of monk fruit extract is an enhancement to the 
antibacterial peptides released during the hydrolysis of milk protein by the yoghurt 
cultures (Abdel-Hamid et al., 2020). 
 
2.5 Prebiotic Fibres and Non-Digestible Carbohydrates 
Dietary carbohydrates are generally classified based on their digestibility by the 
small intestine: “easily digestible” or “non-digestible” (Figure 7).  Digestible 
carbohydrates are either absorbable without digestion or are enzymatically degraded 
in the small intestine, releasing glucose into the bloodstream and stimulating an insulin 
response.  Included in this group are starches and sugars, such as glucose, fructose, 
sucrose, and lactose.  Conversely, non-digestible carbohydrates such as fibre and 
resistant starch escape degradation by enzymes in the small intestine and instead 
travel to the large intestine where they undergo fermentation by resident 
microorganisms (Singh et al., 2017).  Dietary fibre is nondigestible carbohydrates found 
in plants, including plant nonstarch polysaccharides, such as cellulose, pectin, gums, 
hemicelluloses, β-glucans, algae derivatives, lactulose, inulins, fructooligosaccharides, 
galactooligosaccharides, xylooligosaccharides, and isomaltooligosaccharides.  
Functional fibres are defined to be isolated, extracted, or synthetic nondigestible 
carbohydrates that have proven physiological benefits in humans.  They include 
isolated, nondigestible fibre from plants (e.g., resistant starch, pectin, and gums), 
animal derived (e.g., chitin and chitosan), or commercially produced carbohydrates 
(e.g., resistant starch, polydextrose, inulin, and indigestible dextrins) (Brownawell et 
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al., 2012).      
 
Figure 7   
Dietary Carbohydrates and Their Potential for Digestion and Absorption in the Human 
Body (Adapted from (Barba, 2019). 
 
2.5.1 Prebiotics 
 Short chain carbohydrates that are non-digestible but fermentable in the colon 
are collectively known as prebiotics.  In order for a food ingredient to be considered a 
prebiotic, it must be i) resistant to gastric acidity, hydrolysis by enzymes, and 
gastrointestinal absorption; ii) fermentable by intestinal microflora; and iii) selectively 
stimulate the growth and/or activity of intestinal bacteria associated with health and 
wellbeing.  Certain indigenous GI bacteria selectively metabolise a prebiotic, allowing 
specific changes in the composition and/or activity of gut microflora thus conferring 
benefit(s) to the host (Gibson et al., 2017).  The benefits of prebiotic compounds 
include an increased absorption of minerals such as calcium, production of vitamins, 
and inhibition of harmful bacteria in the GIT; in addition to increased satiety leading to 
a decrease in calorie intake which can support weight control (Gomes Da Silva et al., 
2017).  Prebiotic and dietary fibre are terms both used to describe food components 
that are not digested in the GIT, however, while all prebiotics are fibre, not all fibre is 
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prebiotic.  Since this is a selective stimulation, modifications to the gut microbiota 
occur at the level of individual strains, and dietary fibre is used by the majority of 
colonic microorganisms.  Based on the number of monomers bound together, 
prebiotics may be classified as: disaccharides, oligosaccharides (3-9 monosaccharide 
units), and polysaccharides (10 or more monomers) (Markowiak & Śliżewska, 2017).  
The most important prebiotics are inulin and oligofructose, which are soluble and 
fermentable fibres.  They are named fructans and cannot be digested by α-amylase or 
other hydrolases in the upper section of the intestinal tract (Gibson et al., 2004). 
 Prebiotics can be found in fruits, vegetables, cereals, and other edible plants.  
Some prebiotics (i.e., inulin) occur naturally in several foods such as leeks, asparagus, 
chicory, Jerusalem artichokes, garlic, onion, wheat, oats, and soybeans.  Since 
prebiotics are naturally contained in fruits and vegetables, they offer a direct approach 
to act as a carbohydrate source for probiotic bacteria and manage the microflora 
through diet.  In addition to the benefits they bring, certain prebiotic sources also 
provide sweetening power while contributing low caloric value, making them potential 
alternatives to artificial sweetening substances.  Foods may be fortified with prebiotic 
ingredients, such as inulin, FOS, and galactooligosaccharides.  These β-linked 
oligosaccharides are polymers of fructose linked by a β (2→1) glycosidic bond.  As the 
β (2→1) bond is resistant to cleavage in the small intestine, these pass into the colon 
where they are metabolised by the gut bacteria and ultimately affect gastrointestinal 
health (Barba, 2019).  
 
2.5.2 Prebiotic Impact on Probiotic Bacteria 
Many studies suggest that a diet rich in non-digestible carbohydrates 
consistently target Lactobacillus and Bifidobacterium in the gut, and these are the 
most popular target genera for prebiotics (Slavin, 2013).  When prebiotics and 
probiotics are combined in a food product, the combination is called a synbiotic (De 
Vrese & Schrezenmeir, 2008).  Prebiotics can also modulate the colonic flora by 
inhibiting pathogens such as Clostridium and Bacteroides (Holzapfel & Schillinger, 
2002).  Besides the established positive impact on microflora, other indirect but 
beneficial effects of prebiotics include production of SCFA (lactic, acetic, propionic, and 
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butyric acid) which may play a role in primary prevention of colorectal cancer, 
immunomodulation, influence on sugar digestion and absorption, and glucose 
metabolism.  As intestinal microbiota are stimulated by prebiotics, fermentation 
activity is determined and concurrently this influences SCFA levels.  Because of 
fermentation in the large intestine, the ingestion of higher quantities of prebiotics may 
lead to GI intolerance symptoms including flatulence, abdominal disorders, and 
diarrhoea, due to osmotic potential and/or excessive fermentation (De Vrese & 
Schrezenmeir, 2008).  Some known prebiotic fibres are associated with impaired 
gastrointestinal tolerance, while other prebiotics exhibit high gastrointestinal 
tolerability (Slavin, 2013).  One study established that the prebiotic source yacon is 
well tolerated and does not cause gastrointestinal problems when ingested at a dose 
of 0.14g/kg daily (Ojansivu et al., 2011).  In addition to the dietary dosage, prebiotic 
effectiveness and stability of inulin-type fructans depends on the DP, which can be 
affected by processing conditions such as temperature or pH, with FOS hydrolysis 
increasing with temperature, and decreasing with an increase in pH (Gomes Da Silva et 
al., 2017). 
 
2.6 The Gut Microbiome 
The gut microbiome (GM) is a complex community of trillions of microorganisms 
that reside in the intestine.  The microbes themselves are an assemblage known as the 
microbiota.  In the past decade, gut microorganisms have been increasingly recognised 
as having a wide variety of fundamental roles and functions which contribute to 
human health.  In addition to playing a central part in modulating immunity and 
protecting against pathogens, the microbiota has been associated with numerous 
chronic conditions including inflammatory bowel disease (IBD), T2DM, and diet 
induced obesity (Ley et al., 2005).  Facultative aerobes are the earliest colonising 
species in the infant gut, with an eventual shift to an anaerobic environment led by 
facultative anaerobes such as lactobacilli, enterococci, and enterobacteria.  A 
commensal enteric microbiota is rapidly acquired creating the complex ecosystem 
characterised by an abundance of diverse inhabitants including protozoa, yeast, 
viruses, and hundreds of species of bacteria.  Amongst the bacteria, Firmicutes and 
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Bacteroidetes predominate, with these two phyla representing more than 90% of the 
gut microbiota (Donaldson et al., 2015).  The structure and composition of the human 
gut microbiome has been implicated in most aspects of health and disease, thus 
modification of microbiota has progressively gained more attention as a treatment for 
several diseases in humans and animals.  Studies have shown that the microbiota in 
obese humans is overall a less diverse composition with a higher abundance of 
Firmicutes, hence displaying a higher Firmicutes: Bacteroidetes ratio (Singh et al., 
2017).  Experiments that transplanted microbes from obese humans into the gut of 
germ-free mice (raised in the absence of any microbial life) exhibited a significant 
increase in body fat percentage, showing that the obese phenotype is transmissible 
(Turnbaugh et al., 2006).  It remains unclear whether an alteration of microbiota leads 
to obesity, or if weight gain leads to changes in the GM.  
It is now understood that the microbiota has the potential to impact human 
metabolism and extract nutrition and energy from foods by synthesising essential 
vitamins and amino acids, and by generating SCFA (Thursby & Juge, 2017).  Many LAB 
and other Firmicutes species are known to be major producers of SCFA, such as 
butyrate, propionate, and acetate, which are thought to strengthen the mucosal 
barrier and act as key metabolic mediators (Zhang et al., 2018).  Through the 
production of metabolic end products, LAB decrease luminal colonic pH to a level that 
pathogens can not withstand.  Many LAB are able to excrete natural antibiotics which 
have a broad spectrum of activity.  Butyrate has a beneficial effect on glucose and 
energy homeostasis, propionate regulates gluconeogenesis and satiety signalling, and 
acetate may play a role in central appetite regulation (Valdes et al., 2018).  Consistent 
with this, observational studies have correlated SCFA with improved postprandial 
glycaemic response, reduced insulin resistance, lower diet-induced obesity and lower 
incidence of T2DM (Ley et al., 2006).  The significance of microbial variability is 
increasingly being recognised, with low microbial diversity directly corresponding to a 
state of disease, known as dysbiosis.  Through studies on twins, it has been established 
that although there is a heritable component to gut microbiota composition, the larger 
determinants are environmental factors such as diet and drugs, and anthropometrics 
(Rothschild et al., 2018).  The diversity of gut microbiota has also been observed based 
on geographic regions and the diets of different cultures were associated with variable 
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microbiota profiles.  Another factor which was correlated with microbiota composition 
is the socio-economical differences among individuals in the same geographic 
provenance.  Dietary intervention is, however, one of the critical contributing factors 
to the microbiome composition and diversity (Senghor et al., 2018). 
2.6.1 Effect of Diet on Microbiota 
Specific types of foods and dietary patterns have been evidenced to induce 
dynamic shifts in existing host bacterial genera, with impact that can be produced in as 
little as 24 hours.  Certain diets are correlated with changes in GM abundance and 
composition, such as the increase in bile-tolerant microorganisms seen with an animal-
based diet, and the increase in Firmicutes resulting from a plant-based diet.  In 
patients with IBS, the low fermentable oligosaccharides, disaccharides, 
monosaccharides and polyols (FODMAP) diet that is commonly prescribed to reduce 
symptoms also reduces overall bacterial count, including the beneficial SCFA producing 
microbes (David et al., 2014). 
The long-term weight gain that is evidenced by a mouse study correlates with 
low microbiota diversity and is also associated with a low intake of dietary fibre (Wang 
et al., 2017).  Because of the well-known causality of the intestinal microbiota on 
human health, some important and necessary research is looking at the effects certain 
food additives have on microbes (Sonnenburg & Bäckhed, 2016).  Common additives 
such as emulsifiers have been shown to affect mouse gut microbiota, promoting colitis 
and metabolic syndrome (Suez et al., 2014).  
2.6.2 Effect of Sweeteners on Microbiota 
2.6.2.1 In Vitro and Animal Studies  
In addition to the general health concerns about NNS, there is a growing body 
of evidence that sugar substitutes have a negative effect on gut microbiome 
composition, and some sweeteners have been reported to induce effects on select 
bacterial genera (Table 2).  NNS stimulate the development of glucose intolerance 
through compositional and functional changes in gut microbiota, which in turn leads to 
sensitivity of the host to metabolic disorders.  One study’s findings demonstrate that 
aspartame, sucralose, and saccharin disrupt the balance and diversity of gut 
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microbiota, mediating a strongly altered glycaemic response which leads to glucose 
intolerance (Suez et al., 2014).  The same authors furthered the proposed association 
of NNS and altered gut microbiota by performing fecal transplantation in germ free 
mice.  When the mice received transplantation with microbes from a saccharin-
consuming donor, metabolic derangements ensued.  The induction of hyperglycaemic 
response in the mice confirms the existence of glucose response mediated by the gut 
microbiome as a result of NNS (Suez et al., 2015).  However, a different author notes 
that there is a limitation presented by the fact that that the dose of saccharin used in 
the experiment was several-fold higher than typical human consumption, therefore it 
is uncertain whether the results could be reproduced in humans (Imamura et al., 
2015). 
NNS were shown to have a functional impact on gut microbiota via 
inflammatory processes that promote the development of chronic disease caused by 
microbiota dysbiosis.  The inflammatory metabolites that are regulated by gut bacteria 
were shown to lead to reduced metabolic activity in mice (Bian et al., 2017c).  
Saccharin consumption induced the development of these metabolites, altering the 
dynamics of gut microbiome development, and causing a pro-inflammatory effect in 
mouse liver (Bian et al., 2017b). 
Ace-K was shown to have a strong direct bacteriostatic effect on E. coli in the 
GM of mice.  The Firmicutes phylum became significantly more abundant, and 
Bacteriodetes showed a trend towards less abundance.  The research showed the 
same bacteriostatic results with administration of saccharin and sucralose (Wang et al., 
2018).  A study of rats that were fed aspartame resulted in a reduction in energy intake 
though they displayed an elevation in fasting glucose levels and impaired insulin 
response.  Aspartame induced distinctive changes in the GM composition with an 
increase in propionate producing bacteria, an effect that was amplified in the obese 
state.  Since propionate is a highly gluconeogenic substrate, this is a potential 
explanation of aspartame’s negative effect on insulin tolerance (Palmnäs et al., 2014).  
Rats that were given a 12-week treatment of sucralose at dosage within the 
range of FDA acceptable daily intake had lower viable counts of aerobic and anaerobic 
faecal bacteria.  A significant increase to intestinal pH was also seen, which is 




(Frankenfeld et al., 2015).  It is suggested that future researches may improve methods 
for sample collection by utilising capsule endoscopy (Hollister et al., 2014).  The first 
work to characterise the human gut enterotype demonstrated the impact of long-term 
diet on the gut microbiome using a combination of diet recall and faecal analysis (Wu 
et al., 2011).  The impact of short-term diet on GM composition was also 
demonstrated using a similar research structure (David et al., 2014).   
Though many studies evidence the ill effects of aspartame on human health, 
human trials on the effects on GM composition are lacking.  There are no studies on 
the effect of aspartame on the GM specifically, however it is completely hydrolysed in 
the small intestine and does not reach the colon (Magnuson et al., 2016).  The faecal 
transplant model has given some informative results for studying the human GM.  
Mice recipients of microbiomes from saccharin consuming human donors resulted in 
an altered microbiome, compared to the control mice.  Saccharin was shown to 
increase the number of bacteria that are associated with obesity, and functionally alter 
the metabolic pathways that are linked to glucose tolerance and obesity (Suez et al., 
2015).  In order to establish some biological plausibility, research has quantified the 
effects of NNS on SCFA production using in vitro faecal culture profiling, which can be 
extrapolated as biomarkers of human microbiome health (Laudisi et al., 2019).  By 
analysing metabolite formation, conclusions may be drawn regarding microbiota 
interaction with NNS.  Indicative of a metabolomic response, Ace-k was shown to 
increase levels of butyrate and pyruvate, and sucralose altered the ratio of butyric and 
propionic acids, compared to a control.  Butyric acid is a known to work against obesity 
and insulin resistance.  Lowered concentrations of these SCFA have been correlated 
with IBS.  SCFA levels were measured in human colon simulators to determine the 
impact of NNS on metabolic activity of microbiota.  A decrease in the number of 
genomes of the Firmicutes was caused by saccharin and sucralose, having a direct 
correlation with reduced levels of SCFA, and linking NNS to disturbances in the normal 
microbial pattern.  Also negatively affecting the microbiota balance, an increase in 
Gram-negative bacteria was observed (Vamanu et al., 2019).    
Changes to microbial and metabolomic patterns can cause physiological 
dysfunctions that trigger chronic disease.  Though it is difficult to translate the findings 
with animal models to gut microbiota interactions in humans, a study was able to 
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show similarity to human pathology of Chron’s disease through a mouse model.  The 
research evidenced dysbiotic changes in the gut microbial ecosystem, and chronic ileal 
inflammation due to sucralose consumption, which can increase susceptibility to colitis 
(Wang et al., 2019a).  NNS induce changes in the gastro-intestinal environment and 
thus of microbiota; which can trigger glucose intolerance (Palmnäs et al., 2014).  Early 
studies have indicated that artificial sweeteners maintain peak insulin concentrations 
and plasma glucose without affecting gut microbiota.  More recently, animal and 
human studies presented specific changes in microbiota as a result of alterations in the 
metabolic pathways which are related to glucose tolerance and dysbiosis in human 
subjects, especially with the ingestion of saccharin (Suez et al., 2014).  Saccharin, ace-k 
and sucralose have been found in the breastmilk of nursing mothers.  Immature 
clearance mechanisms in infants means lower filtration rates that could equate to 
intake levels exceeding the ADI which is established for adults.  Because healthy gut 
microbiota plays an important role in protection against chronic disease during early 
infancy, NNS ingestion by infants is particularly concerning (Sylvetsky, 2018). 
2.6.3 Effect of Probiotics and Prebiotics on the Microbiome 
Reduction of gastrointestinal infections and disorders can be achieved through 
the intake of probiotics.  Increases in Lactobacillus and Bifidobacterium intake have 
been described as an effective defence against gut dysbiosis.  These effects may be 
due to diverse modes of action such as direct antimicrobial activity through production 
of bacteriocins, or competition for binding sites or stimulation of colonocyte function.  
Changes in GM function and composition are marked features of obesity, and probiotic 
bacteria can create a balance between pathogens and microbiota.  Strains such as 
Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, and Enterococcus are 
used as a therapeutic strategy to treat and prevent obesity via modulation of 
microbiota.  Three main mechanisms of obesity treatment by probiotics have been 
defined as follows: 1) antagonistic effects on pathogenic microorganism growth and 
competitive adherence to intestinal mucose and epithelium (antimicrobial activity), 2) 
increased intestinal mucus layer production and reduced intestinal permeability 
(barrier function), and 3) modulation of the gastrointestinal immune system 
(immunomodulation) (Cerdó et al., 2019).  
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It has been confirmed by animal studies and human clinical trials that the intake 
of prebiotics can modify both intestinal microbiota composition and abundance.  FOS 
and GOS are known substrates to stimulate the growth of Lactobacillus and 
Bifidobacterium in the gut.  As an indirect effect resulting from the growth of these 
beneficial species, prebiotic yacon root interacts with the immune system, influencing 
the production of cytokines and creating an immunomodulatory effect in both humans 
and animals (Gibson & Roberfroid, 1995).  In a study which administered yacon flour to 
mice, an increase in bifidobacteria and lactobacilli counts was observed, and 
enterobacteria population was significantly diminished in the intestinal microbiota, 
compared to the non-yacon consuming control group (Bibas Bonet et al., 2010).  Other 
prebiotics have variable effects on the microbiota due to different degrees of 
polymerisation.  The prebiotic metabolism end products, organic acids and SCFA, are 
known influencers of the intestinal microenvironment, reducing colonic pH, increasing 
beneficial microbe inhabitants and blocking pathogens.  Populations of some intestinal 
bacteria decreased after intake of prebiotics, possibly due to competitive inhibition 
from other intestine colonising species that preferentially ferment prebiotics (Wang et 
al., 2020).   
Synbiotics combine probiotic and prebiotic components with the aim of 
increasing the abundance of beneficial microbes and correcting the disruption to gut 
microbiota which may be observed due to obesity or an imbalanced diet.  A clinical 
trial evaluated body composition and biomarkers of obesity as related to the intake of 
a combination of probiotic bacteria (L. acidophilus, B. bifidum) and prebiotic GOS.  
Synbiotic supplementation increased the proportion of species known to be correlated 
with lower body mass and BMI, such as Lactobacillus and Bifidobacterium.  Other 
beneficial effects include a decrease in fasting blood glucose level and a positive effect 
on other metabolic parameters (Markowiak & Śliżewska, 2017).  Furthermore, 
significant alterations in gut microbiota composition were observed.  The synbiotic 
intervention created an increase in the butyrate-producing genus Ruminococcus, thus 
benefitting colonocytes and protecting against toxic metabolites that are linked to 




3 Materials and Methods 
3.1.1 Materials  
The starter used in this study was a commercial food-grade freeze dried co-
culture of Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus 
(NPSelection, United Kingdom).  Starter cultures were stored at 5°C until used.  Three 
alternative sweeteners were selected, lucuma fruit and yacon root, both in the form of 
a ground whole food powder/flour (Buy Whole Foods Online, United Kingdom), and 
monk fruit containing 25.0% Mogroside V, a high-intensity sweetening powder 
extracted from the luo han guo fruit (Buddha Fruit, United Kingdom).  The sweeteners 
were used as they were without any further purification.  UHT skimmed milk and table 
sugar were purchased from a local supermarket (Tesco, United Kingdom).  All other 
chemicals used were of analytical grade and purchased from Sigma-Aldrich (Dorset, 
United Kingdom). 
3.1.2 Sweetener Concentration 
A preliminary tasting was conducted in order to determine the sweetening 
power and define the concentration of sweetener to be used in the experiments.  A 
standard 1.0%wt sucrose solution was prepared, along with two concentrations of the 
sweeteners (1.0% and 5.0%wt).  Two individuals evaluated the relative sweetness of 
yacon, lucuma, and monk fruit, against the sucrose solution, drinking water and 
pausing for 10 minutes in between.  The lucuma and yacon samples had barely any 
perceived sweetness at 1.0%wt and the ideal concentration was determined to be 
5.0%wt.  The solubility of lucuma and yacon decreased dramatically when the 
concentration was above 5.0%wt.  
3.1.3 Innoculum Preparation 
To prepare the mother culture, starter culture was inoculated into the sterile 
UHT skimmed milk in the amount of 1g per 100mL then placed in an incubator 
(Thermo Scientific Herathern Incubator IGS60) for 18 hours at 45°C.  This prepared 
mother culture was then placed into storage and held at -25°C. 
 
39 
3.2 Acidification Profiling 
The sweeteners were tested for the effect of several concentrations on pH 
during fermentation.  Acidification profiling of cultured milk in the presence of the 
selected sweeteners was performed according to Oliveira et al. with some 
modifications (Oliveira et al., 2009).  Three different sweeteners (lucuma, yacon, and 
monk fruit) were added at 5.0%wt into sterile skimmed milk.  50 mL aliquots were 
prepared containing 50% (25 mL) of pure skimmed milk with sweetener and 50% (25 
mL) of pre-activated mother culture made with 1.0% starter.  Additionally prepared 
was a control series of 6 tubes of only pure milk and pre-culture, without any added 
sweetener.  All tests were run in triplicate.  Tubes were mixed using a vortex (Velp 
Scientific 2x3 Advanced Vortex Mixer) and placed into 45°C incubator for 
fermentation.  After taking the initial readings for the zero-hour samples, pH was 
monitored at one-hour intervals using a digital glass electrode pH-meter (Hanna 
Instruments pH300, United States).  Readings were taken every hour up until 5 hours 
when fermentation was complete (pH reached 4.5) and the results were plotted for 
acidification profiling.  Aliquots from each time interval were stored at -25°C until used 
for the methylene blue test.  
3.2.1 Kinetic Parameters 
The acidification profiling data was used to calculate the maximum acidification 
rate, or vmax, as the time variation of pH units, expressed as time in hours (h-1).  The 
following kinetic parameters were also calculated during the incubation period: tmax, or 
the time required to reach vmax; tpH5.0, or the time at which the fermentation reached 
pH 5.0; tpH4.5 (tf), or the time at which the fermentation reached pH 4.5 indicating the 
completion of fermentation (Oliveira et al., 2009).  The reported values are averages 
from three replications. 
3.2.2 Methylene Blue Test 
Lactobacillus delbrueckii subsp. bulgaricus are characterised as Gram-positive, 
facultatively anaerobic, non-motile and non-spore-forming, rod-shaped bacterium, 
with a cell size range of 0.5-0.8 x 2.0-9.0 μm (Teixeira, 2014).  Streptococcus 
thermophilus are a Gram-positive bacterium with non-motile spherical to ovoid cells of 
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0.7 - 0.9 μm in diameter (Harnett et al., 2020).  Methylene blue staining was employed 
to determine cell viability based on the uptake of the dye by dead or injured cells.  
Viability is defined as the relative proportions of colourless (live) cells in a whole 
population (Evans, 2006).  100 uL of 10-1 culture dilution was wet mounted onto a glass 
slide with pipette followed by one drop of 0.01% methylene blue dye, allowing excess 
to drain off the slide onto a paper towel.  Living cells are able to reject the dye and 
dead cells absorb it and are stained blue due to the uptake of dye.  The slides were 
viewed under the compound microscope (Leica Microsystems Model DMR, Illinois, 
United States), and pictures were taken under 400x magnification (IC Capture, Imaging 
Source, North Carolina, United States).  Images displayed the distinction between live 
and dead cells, and cells which appear blue were considered to be nonviable.  Cell 
viability was calculated as a percentage of live cells to total number of cells. A square 
measuring 150x150 pixels was placed over the slide images, with 5 locations selected 
at random, to complete a manual cell count.     
3.2.3 Statistical Analyses 
The effect of the selected natural alternative sweeteners on the acidification of 
skimmed milk during fermentation and cell viability (methylene blue test) was 
investigated with a one-factor-at-a-time experimental design.  A descriptive analysis 
was conducted to ensure all data collected was normally distributed (Shapiro-Wilk 
test) and had equal variances (Levene test).  One-way analysis of variance (ANOVA) 
and Tukey’s Post Hoc tests were performed using IBM SPSS Statistics 22 to examine if 
there was a significant difference among the samples.  The values were considered 
significantly different when p < 0.05.  Values presented are the means of experiments 






4 Results and Discussion 
4.1 Acidification Profiling  
Figure 8 shows the change in pH of the cultured milk samples with 5.0%wt 
sweetener, incubated at 45°C for 5 hours.  A control without any sweetener was 
included for comparison purposes.  The general trend of pH change was a slower more 
gradual start as this was the lag phase of bacterial growth, with the pH dropping more 
rapidly as the LAB produced more lactic acid at a later stage as it was fermenting and 
the bacterial growth rate entered the exponential, or log phase.  This growth curve 
was a straighter line with less of a slope when compared to the sigmoid or bell shaped 
curve that is demonstrated with a comparative study of an acidification profile of in 
the presence of inulin, which exerts a stronger prebiotic effect than our sweeteners 
(Oliveira et al., 2009).  This study utilised the same probiotic co-culture (Lactobacillus 
delbrueckii subsp. bulgaricus and Streptococcus thermophilus) as in this study, so it is 
possible that the differences in the acidification profile are due to the presence of 
different additives in the milk which alter the growth characteristics and dynamic of 
the probiotic co-culture. 
All samples had a similar pH at the beginning of fermentation but pH dropped 
faster for the control than all three sweeteners from time 1 hour and towards the end 
of fermentation.  The fermentation of the control samples (represented by pH 4.5) 
completed at mean of 4.61 hours.  Among the sweetener samples, yacon exhibited the 
slowest decrease in pH, while lucuma dropped the fastest.  After 5 hours into the 
fermentation, the pH of the lucuma sample has dropped by 18.76%, compared to pH 
change of yacon which declined by 15.54%.  The results of the acidification tests 
suggest that there was a possible inhibition of the starter cultures in the presence of 
lucuma, yacon, and monk fruit, compared to the cultured milk without added 
sweetener.  While it was expected that there would be an accelerated effect in 
fermentation, it took slightly longer to complete (represented by pH value 4.5) in 





products, representing the highly specific nature of strains and the variation in their 
complex nutrition requirements.  LAB can be exposed to osmotic stress with the 
addition of salt or sugar in a food product, and sweeteners have been shown to display 
an influence on the growth of strains of Lactobacillus and Streptococcus (Vinderola et 
al., 2002).  It is possible that the sweeteners used in this study presented an impact 
such as this.   
Polyphenols or other bioactive compounds that exist in the sweeteners could 
either impair or enhance LAB (Terpou et al., 2019).  The natural fibres, pigments, 
alkaloids, bioactive peptides and phenolic acids contained in Andean crops such as 
yacon and lucuma have been shown to have antibacterial properties and this may 
explain inhibitory activity (Glorio et al., 2008).  Antibacterial bioactivity has been 
identified in monk fruit, confirming the possibility that it may have hindered microbial 
growth in this experiment (Abdel-Hamid et al., 2020).   
 
4.2 Percent Viability Calculation 
Bacterial viability refers to the ability of a cell to grow and subsequently 
generate a colony of cells under defined environmental conditions, and this is 
considered essential criterion for the functionality of probiotics in terms of health-
promoting properties (Terpou et al., 2019).  Figure 9 shows the representative light 
microscope images of the cultured milk samples after 5 hours of fermentation.  
Methylene blue staining was employed to cultured milk samples.  Under magnification, 
clusters of dead or injured cells that have taken up the blue dye were visible along with 
the live cells which were clear or transparent.  The microscopic images show that there 
were more dead or injured cells in the cultured milk samples with sweeteners 
compared to the control.  This observation explains the slower acidification rate in the 
samples with sweeteners.  The sweeteners appear to possess some antibacterial 
activity towards the co-culture although further investigation is required to verify this.  
A rough estimation was made of the viable to dead cell ratio from the 
microscopic images and results are presented in Table 4.  All samples have a similar 
percentage viability, ranging from 75% to 85%.  Statistical analysis results show that 
there is no significant difference (p > 0.05) in cell viability percentage between all 
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treatment groups, although the control does have a slightly higher viability percentage 
compared to the samples with sweeteners.  It should be noted that the results are a 
rough estimate of call viability based on manual cell count on microscope images.  A 
more accurate method such as flow cytometry would be needed for a more definite 
result.  Since LAB strains may exhibit different responses to stress factors, this can 
affect cell membrane integrity and consequently affect viable cell counts.  It is worth 
mentioning that some studies have evidenced that dead cells can also provide 






Methylene Blue Stain – Slide Snapshot 400x Magnification  
Lactobacillus delbrueckii subsp. bulgaricus cells measure 0.5-0.8 x 2.0-9.0 μm (Teixeira, 2014). 








In order to isolate and enumerate colony numbers of lactic acid bacteria, the 
pour plate technique was employed by serial dilution of each culture and sweetener 
treatment in addition to a control; incubated anaerobically in triplicate according to 
standard procedures.  Plate counts showed positive growth on an agar medium, 
however the colony counts were inconsistent with tenfold serial dilutions, rendering 
the tests inconclusive.  If it was possible to get back into the lab, we would have 
engaged in additional viability analysis including additional rounds of plate counting.   
Although it is still widely used, the methylene blue dyeing method is thought to 
overestimate viability, and there is high potential for human error (Evans, 2006).  Flow 
cytometry is where cells are counted by passage through a laser beam, and this is a 
more reliable method of producing accurate viability determinations, however this 
apparatus was not available at our facility.   
Isolated oligosaccharides have been the representative prebiotic agents in the 
majority of the current body of research.  It should be taken into account that the 
yacon and lucuma used in this project are a commercial product and unrefined raw 
material, and there are currently no consistency standards for the production of the 
sweeteners.  Consequently, it is possible the prebiotic fibres are not readily available 
to be metabolised by probiotic bacteria.  Additionally, carbohydrate content in the 
crops could vary considerably based on factors such as cultivar variety, harvest time 
and location, and post harvest storage conditions.  In yacon and lucuma, there are 
other components present that may have affected bacterial growth.  The monk fruit 
employed in this project is in a concentrated form, and it is known to contain medicinal 
compounds which have antibacterial properties and have been shown to supress 
bacterial growth.   
 
4.3.2 Future Research 
Yacon and lucuma contain bioactive components that may have affected 
bacterial growth.  Monk fruit is in a concentrated form and is known to contain 
medicinal compounds which have antibacterial properties and have been shown to 
supress bacterial growth.  Any insights to better understand the precise compostion of 
the sweeteners would benefit this topic of research.  Once these compounds are 
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identified then we could gain a better understanding of the mechanisms of inhibition 
components that impact the acidification process. 
Future experiments could employ chromatographic techniques coupled with a 
sensitive detector such as gas chromatography-mass spectroscopy (GC-MS), which 
would be advantageous in order to measure the change in sugar composition in the 
milk and to analyse the metabolic products as they breakdown during fermentation.   
It remains controversial whether a potential prebiotic agent must selectively 
stimulate only one or a limited number of probiotics, and a major emerging area of 
research is the focus on the specificity of prebiotics for gut bacteria (Wang et al., 
2020).  Using variations in starter cultures in these experiments would be a insightful 
way to investigate growth dynamics and explore the selective stimulation of tailored 
prebiotics for the specific enrichment of gut probiotic populations at the strain level.   
From a sensory point of view, the flavor profiles of yacon and lucuma show 
promise to enhance food product development and appeal to a wider population 
beyond the niche market.  For instance, the natural essence of lucuma is a caramel 
butterscotch type flavour that would lend well to applications such as puddings, 
desserts, and dairy based treats.  A sensorial component to this research area can 
assist in formulating with the sweeteners and attaining optimal sweetness potency, 
appearance, colour, texture, flavour, and overall acceptibility.  An evaluation of the 
various physical, bioactive, and quality parameters, would greatly help to guide novel 
food innovation of products that will maintain a comparable sensory profile to sucrose 
sweetened foods without impacting consumer acceptability.  Reformulation and new 
development using novel ingredients that can replace sucrose and create interesting 
flavours while also offering functional nutrition benefits, should be examined using 
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